1. Design, Synthesis, and Biological Evaluation of Proteolysis-Targeting Chimeras as Highly Selective and Efficient Degraders of Extracellular Signal-Regulated Kinase 5
    Pengming Pan et al, 2023, Journal of Medicinal Chemistry CrossRef
  2. Biological and Molecular Effects of Small Molecule Kinase Inhibitors on Low-Passage Human Colorectal Cancer Cell Lines
    Falko Lange et al, 2014, BioMed Research International CrossRef
  3. Transforming growth factor-β downregulates sGC subunit expression in pulmonary artery smooth muscle cells via MEK and ERK signaling
    Lili Du et al, 2019, American Journal of Physiology-Lung Cellular and Molecular Physiology CrossRef
  4. Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation
    Tsukasa Nakamura et al, 2018, International Journal of Molecular Sciences CrossRef
  5. Kinase-Modulated Bioluminescent Indicators Enable Noninvasive Imaging of Drug Activity in the Brain
    Yan Wu et al, 2023, ACS Central Science CrossRef
  6. Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?
    Yong Weon Yi et al, 2021, International Journal of Molecular Sciences CrossRef
  7. Capsaicin Induces Apoptosis in KSHV-Positive Primary Effusion Lymphoma by Suppressing ERK and p38 MAPK Signaling and IL-6 Expression
    Misato Moriguchi et al, 2019, Frontiers in Oncology CrossRef
  8. Cell lines of human melanoma and their xenograft with braf or nras mutations a targets for targeted therapy. Reviews
    I. N. Mikhaylova et al, 2019, Russian Journal of Biotherapy CrossRef
  9. BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors
    Dario Talloa et al, 2022, Cancers CrossRef
  10. Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells
    Kyu Sic You et al, 2021, Cancers CrossRef
  11. Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
    Kyu Sic You et al, 2021, Pharmaceuticals CrossRef
  12. Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling
    Alexandru Nita et al, 2021, Cells CrossRef
  13. Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer
    Woo-Jeong Jeong, 2014, World Journal of Gastroenterology CrossRef
  14. Multiparametric Analysis of Oncology Drug Screening with Aqueous Two-Phase Tumor Spheroids
    Pradip Shahi Thakuri et al, 2016, Molecular Pharmaceutics CrossRef
  15. Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors
    Xuguang Zhu et al, 2018, Oncotarget CrossRef
  16. Targeted drug combination therapy design based on driver genes
    Lilian Zsákai et al, 2019, Oncotarget CrossRef
  17. Vemurafenib Combined With Trametinib Significantly Benefits the Survival of a Patient With Stage IV Pancreatic Ductal Adenocarcinoma With BRAF V600E Mutation: A Case Report
    Ziyao Wang et al, 2022, Frontiers in Oncology CrossRef
  18. Study of Molecular Mechanism of the Interaction Between MEK1/2 and Trametinib with Docking and Molecular Dynamic Simulation
    Sh. Hashemzadeh et al, 2019, Interdisciplinary Sciences: Computational Life Sciences CrossRef